Immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation

Immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation

Aim.To analyze the modes of immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation (NODAT) in kidney recipients. Materials and methods.The retrospective analysis included data from 1367 recipients (755 men and 612 women) who lived more than one year after NODAT an...

Full description

Bibliographic Details
Main Authors: S. S. Allazova, M. S. Novikova, O. N. Kotenko, E. M. Shilov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2020-12-01
Series:Терапевтический архив
Subjects:
new-onset diabetes after transplantation
risk factors
kidney allotransplantation
insulin resistance
tacrolimus
cyclosporin a
glucocorticoids
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/60278/43444

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/60278/43444

Similar Items